QQ客服 官方微博 反馈留言

	Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
	Sun, Chengcao; Huang, Chuanfeng; Li, Shujun; Yang, Cuili; Xi, Yongyong; Wang, Liang; Zhang, Feng; Fu, Yunfeng*; Li, Dejia*
刊名	Oncotarget
	2016
卷号	7期号:7页码:8341-8359
关键词	Hsa-miRNA-326 (miR-326) apoptosis cyclin D1 non-small cell lung cancer (NSCLC) proliferation
DOI	10.18632/oncotarget.7071
URL标识	查看原文
WOS记录号	WOS:000370325900076
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3315632
专题	中南大学
作者单位	1.[Xi, Yongyong 2.Sun, Chengcao 3.Yang, Cuili 4.Li, Dejia 5.Li, Shujun 6.Wang, Liang 7.Huang, Chuanfeng 8.Zhang, Feng] Wuhan Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430071, Peoples R China.
推荐引用方式 GB/T 7714	Sun, Chengcao,Huang, Chuanfeng,Li, Shujun,et al. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.[J]. Oncotarget,2016,7(7):8341-8359.
APA	Sun, Chengcao.,Huang, Chuanfeng.,Li, Shujun.,Yang, Cuili.,Xi, Yongyong.,...&Li, Dejia*.(2016).Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development..Oncotarget,7(7),8341-8359.
MLA	Sun, Chengcao,et al."Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.".Oncotarget 7.7(2016):8341-8359.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。